Josel D Ruiz
Overview
Explore the profile of Josel D Ruiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dahi P, Kenny S, Flynn J, Devlin S, Ruiz J, Chinapen S, et al.
Leuk Lymphoma
. 2023 Sep;
64(14):2279-2285.
PMID: 37690007
This study aims to evaluate the predictive value of routine pulmonary function testing (PFT) at the 12-month mark post-autologous hematopoietic cell transplant (AHCT) in identifying clinically significant lung disease in...
2.
Lin R, Kim S, Brown S, Elko T, Ruiz J, Hanley D, et al.
Blood Adv
. 2023 Apr;
7(14):3501-3505.
PMID: 37078703
No abstract available.
3.
Scordo M, Gilbert L, Hanley D, Flynn J, Devlin S, Nguyen L, et al.
Blood Adv
. 2022 Nov;
7(8):1536-1544.
PMID: 36409612
There are no standard treatments to prevent or hasten the recovery from severe conditioning-regimen-induced thrombocytopenia occurring after autologous hematopoietic cell transplantation (auto-HCT). We conducted an open-label, single-arm pilot study of...
4.
Nawas M, Sanchez-Escamilla M, Devlin S, Maloy M, Ruiz J, Sauter C, et al.
Blood Adv
. 2022 Aug;
6(22):5898-5907.
PMID: 35977079
Endothelial activation and stress index (EASIX) predicts nonrelapse mortality (NRM) when assessed before hematopoietic cell transplantation (HCT). We sought to determine whether changes in EASIX after HCT may be an...
5.
Dahi P, Lin A, Scordo M, Flynn J, Devlin S, Ruiz J, et al.
Transplant Cell Ther
. 2022 May;
28(8):485.e1-485.e6.
PMID: 35545213
High-dose melphalan is one of the main cytotoxic DNA alkylating agents and is used in many transplantation conditioning regimens. Studies have shown a wide range of drug exposure when a...
6.
Lin A, Brown S, Maloy M, Ruiz J, Devlin S, DeRespiris L, et al.
Leuk Lymphoma
. 2022 Feb;
63(7):1686-1693.
PMID: 35142567
Given prophylactic methotrexate (MTX) is often held in the setting of toxicity we investigated the impact of omitting minidose-MTX dose(s). Outcomes were compared between patients who had 1-3 doses omitted...
7.
Lakkaraja M, Scordo M, Mauguen A, Cho C, Devlin S, Ruiz J, et al.
Blood Adv
. 2021 Nov;
6(3):1054-1063.
PMID: 34788361
Traditional weight-based dosing results in variable rabbit antithymocyte globulin (rATG) clearance that can delay CD4+ T-cell immune reconstitution (CD4+ IR) leading to higher mortality. In a retrospective pharmacokinetic/pharmacodynamic (PK/PD) analysis...
8.
Reingold R, Monnier J, Ardigo M, Stoll J, Pena M, Nanda J, et al.
Transplant Cell Ther
. 2021 Sep;
28(1):51.e1-51.e14.
PMID: 34571213
Reflectance confocal microscopy (RCM) allows noninvasive, real-time evaluation of the skin at a resolution akin to histopathology (HP), but its application in cutaneous graft-versus-host disease (GVHD) has not been extensively...
9.
Bewersdorf J, Derkach A, Gowda L, Menghrajani K, DeWolf S, Ruiz J, et al.
Leuk Lymphoma
. 2021 Sep;
62(14):3394-3401.
PMID: 34477024
The role of allogeneic hematopoietic cell transplant (allo-HCT) as consolidation after initial venetoclax therapy and the efficacy of venetoclax salvage therapy for relapse after allo-HCT in patients with acute myeloid...
10.
Tomas A, Whiting K, Maloy M, Ruiz J, Devlin S, Sanchez-Escamilla M, et al.
Bone Marrow Transplant
. 2021 Jul;
56(11):2749-2754.
PMID: 34253878
The post-transplant scoring system (PTSS), developed by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy, is based on three independent post-transplant risk factors: grade of acute graft-versus-host disease,...